Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

Lancet

11 September Sep 2009 16 years ago
  • Marc S Sabatine, Elliott M Antman, Petr Widimsky, Iftikhar O Ebrahim, Robert G Kiss, André Saaiman, Rostislav Polasek, Charles F Contant, Carolyn H McCabe, Eugene Braunwald (Centro Cardiologico Monzino: G. Marenzi)
QR Code

Allegati